Breaking News

Overlook Industries Purchases MA Facility

By Kristin Brooks | February 20, 2014

Names exclusive providers in Germany, France and PR

Overlook Industries, Inc. has recently purchased the entire facility that houses the company’s operations in Easthampton, MA. The company will be taking over a significantly larger portion of the 10,000 sq.-ft. facility, nearly doubling usable space. Preliminary plans include the expansion of manufacturing and an additional clean room.
“The purchase of this facility demonstrates Overlook’s commitment to our customers that we are a stable and dedicated supporter of their filling operations. We want to send a strong message to supply chain that we are prepared to provide an uninterrupted source of custom OneShot single-use filler needles and Freedom Filler kit fluid path assemblies long into the future,” said president John Morin.
The company has also named Hebmüller SRS Technik, a provider of customer-optimized valve solutions, as its exclusive distributor of Germany. Additionally, Poliflux was named an exclusive distributor of France and Pharmaceutical Processes Systems, Inc. was named an exclusive distributor of Puerto Rico. Poliflux specializes in the implementation of fluids for biotech pharmaceutical, cosmetic, food and other industries, and PPS supplies high quality materials and equipment to these industries.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important